Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Ippazio Cosimo AntonazzoEmanuel RaschiLuca VignatelliElisa BaldinTrond RiiseRoberto D'AlessandroFabrizio De PontiElisabetta Poluzzi

Published in: Drug safety (2018)

A heterogeneous pharmacological profile of identified classes emerged. Low strength of evidence and conflicting results highlighted the difficulties in addressing the possible contribution of drugs in MS occurrence. Methodological advances are needed, especially to control the confounding role of underlying disease for specific drug classes.

Keyphrases

multiple sclerosis
risk assessment
mass spectrometry
high resolution
ms ms
emergency department